P2RX7 and graft versus host disease: The P2X7 antagonist BBG (twice weekly for 4 weeks) also reduced weight loss, liver inflammation and inflammatory cytokine expression or release, as well as decreasing P2X7 in allogeneic mice with GVHD [114].